Cholesterol Drugs May Boost Outcomes After Bypass
People taking a statin had lower risk of dying in weeks after the heart surgery, researchers sayContinue Reading
People taking a statin had lower risk of dying in weeks after the heart surgery, researchers sayContinue Reading
Increases reported for both types of proceduresContinue Reading
Damage to thinking and memory less than with radiation for entire brain, while survival is similar, study findsContinue Reading
Damage to thinking and memory less than with radiation for entire brain, while survival is similar, study findsContinue Reading
Compared to Yervoy, nivolumab more than doubled time to disease progression, researchers foundContinue Reading
Ibrutinib, obinutuzumab slowed progression of common leukemia, non-Hodgkin lymphomaContinue Reading
No survival difference seen for patients spared surgery, study saysContinue Reading
Study finds effect seems to extend to people exposed to secondhand smoke, tooContinue Reading
Patients given nivolumab reported fewer side effects, longer survival than those receiving usual chemo agentContinue Reading
Finding might one day help doctors better choose patients to receive Keytruda, study saysContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.